NVTA: Invitae Corporation - Summary | Jitta

Invitae Corporation

NYSE:NVTA

Notice
Stock data is unavailable or the company’s delisted.
Price
$0.00
Loss Chance
54.3%
2.11JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (38)
Recent Business Performance (56)
Financial Strength (35)
Return to Shareholders (13)
Competitive Advantage (47)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2022
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.11
100.00%
3.07
432.53%
Health Care Services
6.04
5.69%
2.09
623.25%
6.12
151.27%
COMPANY DESCRIPTION
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.